Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.

UNLABELLED Contrary to hospital exposure, little is known about the indoor fungal exposure of hematology patients at home. The aim of our study was to investigate the mold exposure of hematology patients both at home and at hospital to assess their invasive aspergillosis (IA) risk. Fungal exposure was assessed by quantifying opportunistic molds at hospital during hospitalization and in homes of 53 hematology patients. IA was diagnosed in 13 of 53 patients and invasive fungal infection (IFI) in one patient. In hospital, no opportunistic species, or low levels of opportunistic species, were found in 98% of weekly controls. Only 2% of hematology intensive care unit (ICU) controls showed a high level of Aspergillus fumigatus spores in corridor air. Five patients IA were hospitalized during these periods. Seven dwellings of 53 (5/14 dwellings of patients with IA/IFI and 2/39 dwellings of non-IA patients) had a percentage of A. fumigatus and Aspergillus flavus to total mold (significant predictor variable of IA/IFI in our study, general linear model, P-value = 0.02) as high as 15%. Maintaining a 'zero Aspergillus' goal at hospital is essential, and establishing specific and individually opportunistic mold monitoring at home could help to further reduce the IA risk through continuous surveillance. PRACTICAL IMPLICATIONS This study emphasizes the fact that preventive measures should not be aimed only at the hospital setting: among patients diagnosed with invasive aspergillosis/invasive fungal infection (IA/IFI), 5 of 14 (36%) were exposed to opportunistic fungal species at home exclusively. Moreover, four of these five patients were living in homes having the highest percentage of Aspergillus fumigatus and Aspergillus flavus (>15%), one of which had 48% of A. fumigatus. Therefore, our work supports the need for a counselor to carry out an environmental survey in patients’ homes.

[1]  V. Raina,et al.  Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation , 2013, Indian Journal of Medical and Paediatric Oncology.

[2]  T. Peláez,et al.  Demolition of a hospital building by controlled explosion: the impact on filamentous fungal load in internal and external air. , 2002, The Journal of hospital infection.

[3]  M. Rupp,et al.  Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients. , 2008, The Journal of hospital infection.

[4]  M. Netea,et al.  Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis , 2012, Journal of Clinical Microbiology.

[5]  B. Hargadon,et al.  Isolation of Aspergillus fumigatus from sputum is associated with elevated airborne levels in homes of patients with asthma. , 2013, Indoor air.

[6]  F. Grenouillet,et al.  Ribosomal and Mitochondrial DNA Target for Real-Time PCR Diagnosis of Invasive Aspergillosis , 2011, Journal of Clinical Microbiology.

[7]  G. Reboux,et al.  qPCR standard operating procedure for measuring microorganisms in dust from dwellings in large cohort studies. , 2014, The Science of the total environment.

[8]  L. Pagano,et al.  Design and Methods , 2022 .

[9]  E. van Wijngaerden,et al.  Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Viscoli,et al.  Bacterial infection prevention after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.

[11]  C. Maslo,et al.  Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.

[12]  F. Derouin,et al.  Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. , 2001, The Journal of hospital infection.

[13]  A. Voss,et al.  Hospital sources of Aspergillus species: New routes of transmission? , 2001 .

[14]  V. Aquino,et al.  The indoor air as a potential determinant of the frequency of invasive aspergillosis in the intensive care , 2013, Mycoses.

[15]  B. Segal,et al.  Infection Control Measures to Prevent Invasive Mould Diseases in Hematopoietic Stem Cell Transplant Recipients , 2009, Mycopathologia.

[16]  A. Warris,et al.  Point-of-use filtration method for the prevention of fungal contamination of hospital water. , 2010, The Journal of hospital infection.

[17]  Michael Boeckh,et al.  Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Kontoyiannis,et al.  Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success , 2011, Bone Marrow Transplantation.

[19]  J. Wingard,et al.  Fungal infection prevention after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.

[20]  D. Kontoyiannis,et al.  Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). , 2006, Haematologica.

[21]  K. Marr,et al.  Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  E. Anaissie,et al.  Factors associated with mortality in transplant patients with invasive aspergillosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Moreau,et al.  [Invasive aspergillosis in intensive care]. , 1995, Annales francaises d'anesthesie et de reanimation.

[24]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.

[25]  C. Viscoli,et al.  Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management? , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Tiina Reponen,et al.  Everyday activities and variation of fungal spore concentrations in indoor air , 1993 .

[27]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[28]  L. Millon,et al.  Appréciation quantitative du risque fongique en cas de travaux en établissements de santé : propositions d’indicateurs d’impact des mesures de gestion du risque infectieux fongique , 2012 .

[29]  P. Vanhems,et al.  Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Gabriel Reboux,et al.  Characteristics of dwellings contaminated by moulds. , 2008, Journal of environmental monitoring : JEM.

[31]  B. Lebeau,et al.  Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). , 2006, The Journal of hospital infection.

[32]  L. Millon,et al.  [Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection]. , 2012, Journal de mycologie medicale.

[33]  L. Pagano,et al.  Treatment Strategies for Invasive Aspergillosis in Neutropenic Patients: Voriconazole or Liposomal Amphotericin-B? , 2011, Journal of chemotherapy.

[34]  R. Piarroux,et al.  Indoor mold concentration in Eastern France. , 2009, Indoor air.

[35]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  D. Kontoyiannis,et al.  Occupation, Lifestyle, Diet, and Invasive Fungal Infections , 2008, Infection.

[37]  A. Streifel,et al.  Ten-year air sample analysis of Aspergillus prevalence in a university hospital. , 2007, The Journal of hospital infection.

[38]  L. Pagano,et al.  Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. , 2011, The Journal of antimicrobial chemotherapy.